These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 2869741)

  • 1. Tardive dyskinesia in young mentally retarded individuals.
    Gualtieri CT; Schroeder SR; Hicks RE; Quade D
    Arch Gen Psychiatry; 1986 Apr; 43(4):335-40. PubMed ID: 2869741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents.
    Gualtieri CT; Quade D; Hicks RE; Mayo JP; Schroeder SR
    Am J Psychiatry; 1984 Jan; 141(1):20-3. PubMed ID: 6140865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tardive dyskinesia in the mentally retarded: comparison of prevalence, risk factors and topography with a schizophrenic population.
    Cohen S; Khan A; Zheng Y; Chiles J
    Acta Psychiatr Scand; 1991 Mar; 83(3):234-7. PubMed ID: 1674398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent neuroleptic therapy and tardive dyskinesia: a literature review.
    Goldman MB; Luchins DJ
    Hosp Community Psychiatry; 1984 Dec; 35(12):1215-9. PubMed ID: 6150891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent psychiatric patients.
    Richardson MA; Haugland G; Craig TJ
    Am J Psychiatry; 1991 Oct; 148(10):1322-8. PubMed ID: 1680296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tardive dyskinesia and other drug-induced movement disorders among handicapped children and youth.
    Gualtieri CT; Hawk B
    Appl Res Ment Retard; 1980; 1(1-2):55-69. PubMed ID: 6121532
    [No Abstract]   [Full Text] [Related]  

  • 7. Postural stability, tardive dyskinesia and developmental disability.
    Ko YG; Van Emmerik RE; Sprague RL; Newell KM
    J Intellect Disabil Res; 1992 Aug; 36 ( Pt 4)():309-23. PubMed ID: 1356038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of tardive dyskinesia.
    Raja M
    Schweiz Arch Neurol Psychiatr (1985); 1996; 147(1):13-8. PubMed ID: 8685689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyskinesia in mentally handicapped women: relationship to level of handicap, age and neuroleptic exposure.
    Farren CK; Dinan TG
    Acta Psychiatr Scand; 1994 Sep; 90(3):210-3. PubMed ID: 7810345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tardive dyskinesia in mentally retarded children, adolescents, and young adults: North Carolina and Michigan studies.
    Gualtieri CT; Breuning SE; Schroeder SR; Quade D
    Psychopharmacol Bull; 1982 Jan; 18(1):62-5. PubMed ID: 6152872
    [No Abstract]   [Full Text] [Related]  

  • 11. Respiratory dyskinesia and dysarthria from prolonged neuroleptic use: tardive dyskinesia?
    Faheem AD; Brightwell DR; Burton GC; Struss A
    Am J Psychiatry; 1982 Apr; 139(4):517-8. PubMed ID: 6121492
    [No Abstract]   [Full Text] [Related]  

  • 12. Dynamics of lip dyskinesia associated with neuroleptic withdrawal.
    Newell KM; Bodfish JW; Mahorney SL; Sprague RL
    Am J Ment Retard; 2000 Jul; 105(4):260-8. PubMed ID: 10934568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of thioridazine and withdrawal dyskinesias on workshop performance of mentally retarded young adults.
    Breuning SE; Davis VJ; Matson JL; Ferguson DG
    Am J Psychiatry; 1982 Nov; 139(11):1447-54. PubMed ID: 6753612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tardive dyskinesia: a concern for the pediatrician.
    Singer HS
    Pediatrics; 1986 Apr; 77(4):553-6. PubMed ID: 2870466
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticholinergic challenge and neuroleptic withdrawal. Changes in dyskinesia and symptom measures.
    Gardos G; Cole JO; Rapkin RM; LaBrie RA; Baquelod E; Moore P; Sovner R; Doyle J
    Arch Gen Psychiatry; 1984 Nov; 41(11):1030-5. PubMed ID: 6149737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of abnormal respiratory movements in schizophrenic, bipolar and mentally handicapped patients with typical tardive dyskinesia.
    Youssef HA; Waddington JL
    Int Clin Psychopharmacol; 1989 Jan; 4(1):55-9. PubMed ID: 2574204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tardive dyskinesia and the behavioral consequences of chronic neuroleptic treatment.
    Gualtieri CT; Guimond M
    Dev Med Child Neurol; 1981 Apr; 23(2):255-9. PubMed ID: 6111511
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroleptic discontinuation and tardive dyskinesia risk.
    Sherr JD; Medoff D; Thaker G
    Am J Psychiatry; 1999 Jul; 156(7):1125-6. PubMed ID: 10401483
    [No Abstract]   [Full Text] [Related]  

  • 19. Strategy for the study of patients at high risk for tardive dyskinesia.
    Kane J; Struve FA; Weinhold P; Woerner M
    Am J Psychiatry; 1980 Oct; 137(10):1265-7. PubMed ID: 6106392
    [No Abstract]   [Full Text] [Related]  

  • 20. Tardive dyskinesia.
    Murray JB
    Genet Psychol Monogr; 1980 Nov; 102(2):161-90. PubMed ID: 6110612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.